Search This Blog

Tuesday, June 11, 2013

Boehringer Ingelheim and Eli Lilly and Company Alliance to Feature 34 Presentations on Type 1 and Type 2 Diabetes at the 73rd American Diabetes Association Scientific Sessions® (NYSE:LLY)

Boehringer Ingelheim and Eli Lilly and Company Alliance to Feature 34 Presentations on Type 1 and Type 2 Diabetes at the 73rd American Diabetes Association Scientific Sessions® (NYSE:LLY)

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.